AR016054A1 - Mezcla de ácidos grasos primarios , uso de la mezcla y método para obtener la misma - Google Patents

Mezcla de ácidos grasos primarios , uso de la mezcla y método para obtener la misma

Info

Publication number
AR016054A1
AR016054A1 ARP980101504A ARP980101504A AR016054A1 AR 016054 A1 AR016054 A1 AR 016054A1 AR P980101504 A ARP980101504 A AR P980101504A AR P980101504 A ARP980101504 A AR P980101504A AR 016054 A1 AR016054 A1 AR 016054A1
Authority
AR
Argentina
Prior art keywords
mixture
fatty acids
primary fatty
mixing
same
Prior art date
Application number
ARP980101504A
Other languages
English (en)
Spanish (es)
Original Assignee
Dalmer Lab Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dalmer Lab Sa filed Critical Dalmer Lab Sa
Publication of AR016054A1 publication Critical patent/AR016054A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Obesity (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
ARP980101504A 1997-04-02 1998-04-02 Mezcla de ácidos grasos primarios , uso de la mezcla y método para obtener la misma AR016054A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CU1997035A CU22723A1 (es) 1997-04-02 1997-04-02 Mezcla de ácidos grasos primarios de alto peso molecular obtenidos de la cera de cana de azúcar y sus usos farmacéuticos

Publications (1)

Publication Number Publication Date
AR016054A1 true AR016054A1 (es) 2001-06-20

Family

ID=5459247

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP980101504A AR016054A1 (es) 1997-04-02 1998-04-02 Mezcla de ácidos grasos primarios , uso de la mezcla y método para obtener la misma

Country Status (19)

Country Link
US (1) US6486205B2 (enExample)
EP (1) EP0969827B1 (enExample)
JP (2) JP4907750B2 (enExample)
CN (1) CN1230158C (enExample)
AR (1) AR016054A1 (enExample)
AT (1) ATE233087T1 (enExample)
AU (1) AU732045B2 (enExample)
BR (1) BR9808470A (enExample)
CA (1) CA2285242C (enExample)
CO (1) CO4940484A1 (enExample)
CU (1) CU22723A1 (enExample)
DE (1) DE69811643T2 (enExample)
DK (1) DK0969827T3 (enExample)
ES (1) ES2192769T3 (enExample)
MY (1) MY120318A (enExample)
PT (1) PT969827E (enExample)
RU (1) RU2217130C2 (enExample)
WO (1) WO1998043631A1 (enExample)
ZA (1) ZA982744B (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4666705B2 (ja) * 1999-12-07 2011-04-06 三井製糖株式会社 消化管潰瘍予防剤または改善剤
US20030203854A1 (en) * 2002-04-23 2003-10-30 Ivo Pischel Composition for effecting serum cholesterol levels
PT1515714E (pt) * 2002-06-17 2009-10-06 Medestea Res & Production S P Compostos oxigenados insaturados de cadeia longa e sua utilização no campo terapêutico, cosmético e nutracêutico
US20050074443A1 (en) * 2003-10-03 2005-04-07 Treadwell Benjamin V. Methods of attenuating autoimmune disease and compositions useful therefor
US20060013842A1 (en) * 2004-07-15 2006-01-19 Matkin John R Natural mixture of long-chain fatty alcohols and long-chain fatty acids, its obtension from animal and vegetable waxes and its nutraceutical uses
US7542034B2 (en) * 2004-09-23 2009-06-02 Conversion Works, Inc. System and method for processing video images
KR100723950B1 (ko) * 2005-01-04 2007-05-31 주식회사 하이폭시 벼과 식물 추출물을 포함하는 허혈성 질환 및 퇴행성뇌질환의 예방 및 치료를 위한 조성물
KR100685681B1 (ko) * 2005-07-26 2007-02-26 전북대학교산학협력단 수수에서 폴리코사놀 또는 옥타코사놀 함량이 높은긴사슬지방을 제조하는 방법
TW200730518A (en) * 2005-10-12 2007-08-16 Sicor Inc Crystalline forms of docetaxel and processes for their preparation
US20070295326A1 (en) * 2006-06-07 2007-12-27 Rafael Almagro Method for obtaining long chain aliphatic alcohols and fatty acids from sugar cane mud and related wax esters
US20080207748A1 (en) * 2007-02-22 2008-08-28 Innovation Labs, Inc. Vitamin c preparation
DE102010052789A1 (de) * 2010-11-27 2012-05-31 Wachs-Chemie Elsteraue E.K. Herstellung und Reinigung von PC-Wachs und deren technische Anwendungen
IT201700089258A1 (it) 2017-08-02 2019-02-02 Pharmanutra S P A Composizione per uso nella prevenzione e nel trattamento di carenza di ferro
KR102429853B1 (ko) * 2017-11-30 2022-08-05 (주)아모레퍼시픽 천연 왁스를 이용한 지방산 조성물 제조방법 및 그에 따라 제조된 지방산 조성물
IT201900007326A1 (it) 2019-05-27 2020-11-27 Alesco Srl Composizioni comprendenti acidi grassi cetilati e loro uso nel trattamento di artriti e stati infiammatori articolari
IT201900007311A1 (it) 2019-05-27 2020-11-27 Alesco Srl Procedimento per la preparazione di una composizione comprendente acidi grassi cetilati
IT201900007329A1 (it) * 2019-05-27 2020-11-27 Alesco Srl Composizioni comprendenti acidi grassi cetilati per uso nel trattamento della mucosa gastrica, diabete e alti livelli di glicemia
CU24638B1 (es) * 2020-02-03 2023-01-16 Centro Nac De Investigaciones Cientificas Suspensión oral con efecto antiulceroso y quimioprotector sobre el cáncer de colon
CU24732B1 (es) * 2021-07-13 2025-02-07 Centro Nac De Investigaciones Cientificas Mezcla de compuestos con altos pesos moleculares, obtenida a partir de la cera de caña de azúcar (saccharum officinarum l.)

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5160207A (en) * 1974-11-22 1976-05-26 Dai Ichi Kogyo Seiyaku Co Ltd Shibosanto kokyuarukooruno bunriho
JPH0610146B2 (ja) * 1985-10-12 1994-02-09 住友精化株式会社 直鎖第１級脂肪族高級アルコ−ルの抽出法
CA2044162A1 (fr) * 1989-10-13 1991-04-14 Jacques Borg Derives des alcools gras a longue chaine, leurs applications, notamment en tant que molecules cytotrophes et cytoprotectrices, et compositions pharmaceutiques les contenant
CU22225A1 (es) * 1990-11-30 1995-01-31 Cent Nac Investig Scient Composicion farmacautica que contiene mezcla de alcoholes alifaticos primarios superiores para el tratamiento de hipercolesterolemia y la hiperlipoproteinemia tipo ii asi como estimulante de la conducta sexual en animales y humanos
CU22229A1 (es) * 1992-09-29 1996-01-31 Dalmer Lab Sa Policosanol, una mezcla de alcoholes alifaticos primarios superiores para hipergregabilidad plaquetaria, los accidentes isquemicos, trombosis e incluso efectividad contra ulceras gastricas quimicamente inducidas y su proceso de obtencion de la caña de azucar. el tratamiento de complicaciones ateroscleroticas tales como la
JPH06122892A (ja) * 1992-10-09 1994-05-06 Nippon Petrochem Co Ltd 粗ワックスの製造方法
CU22412A1 (es) * 1993-11-09 1996-01-31 Dalmer Lab Sa Una mezcla natural compuesta por alcoholes alifaticos primarios superiores obtenidos de la cera de abejas para el tratamiento de las ulceras gastricas y duodenales que presenta tambien actividad antiinflamatoria
US5554379A (en) * 1994-06-20 1996-09-10 Kv Pharmaceutical Company Long acting GI and esophageal protectant
JP2804445B2 (ja) * 1994-11-30 1998-09-24 ラボラトリオス ダルマー ソシエダッド アノニマ 胃潰瘍および十二指腸潰瘍の処置剤および抗炎症剤
US6039950A (en) * 1995-04-14 2000-03-21 University Of Southern California Pharmaceutical grade saw palmetto
US6080787A (en) * 1997-02-21 2000-06-27 Abbott Laboratories Methods for reducing the incidence of necrotizing enterocolitis
AUPO605097A0 (en) * 1997-04-07 1997-05-01 James Cook University Of North Queensland Food grade wax and process for preparing same

Also Published As

Publication number Publication date
AU732045B2 (en) 2001-04-12
RU2217130C2 (ru) 2003-11-27
JP2012067119A (ja) 2012-04-05
EP0969827A1 (en) 2000-01-12
WO1998043631A1 (en) 1998-10-08
CN1258218A (zh) 2000-06-28
MY120318A (en) 2005-10-31
PT969827E (pt) 2003-07-31
BR9808470A (pt) 2000-05-23
ES2192769T3 (es) 2003-10-16
CU22723A1 (es) 2002-02-28
US20020058705A1 (en) 2002-05-16
CA2285242C (en) 2008-12-16
CO4940484A1 (es) 2000-07-24
HK1029054A1 (en) 2001-03-23
ATE233087T1 (de) 2003-03-15
ZA982744B (en) 1998-10-08
JP2001518092A (ja) 2001-10-09
CA2285242A1 (en) 1998-10-08
DE69811643D1 (de) 2003-04-03
CN1230158C (zh) 2005-12-07
DE69811643T2 (de) 2003-12-24
AU7349498A (en) 1998-10-22
JP4907750B2 (ja) 2012-04-04
EP0969827B1 (en) 2003-02-26
US6486205B2 (en) 2002-11-26
DK0969827T3 (da) 2003-06-16

Similar Documents

Publication Publication Date Title
AR016054A1 (es) Mezcla de ácidos grasos primarios , uso de la mezcla y método para obtener la misma
PT82186B (pt) Processo para a preparacao de novos derivados de gama-ciclodextrina e de composicoes farmaceuticas que os contem
DE69534306D1 (de) Arzneimittel
ATE34078T1 (de) Arzneiform zur oralen verabreichung sowie verfahren zu deren herstellung durch gefriertrocknen einer oel-in-wasser-emulsion.
CN1097735A (zh) 脂肪酸衍生物和含有脂肪酸衍生物的药物组合物
AU3435497A (en) Autocross-linked hyaluronic acid and related pharmaceutical compositions for the treatment of arthropathies
EA200400149A1 (ru) Бензотиепины, обладающие активностью ингибиторов перемещения желчных кислот в подвздошной кишке и поглощения таурохолата
ES2195175T3 (es) Preparacion farmaceutica que comprende acido eicosapentaenoico y/o acido estearidonico.
ES2038643T3 (es) Procedimiento para la obtencion de una composicion farmaceutica topica.
NZ335736A (en) 3-(3-{[3-(3-chloro-phenyl)-propyl]-methanesulfonyl-amino}-propyl)-benzoic acid and similar compounds for the treatment of osteoporosis
DE69809074D1 (de) Herstellung von arzneimitteln
PT90764A (pt) Processo para a preparacaode um produto farmaceutico compreendendo um estrogenio e um anti-estrigenio e de composicoes farmaceuticas que os contem
AR012294A1 (es) Derivados de sulfonamida, un procedimiento para su preparacion, composiciones farmaceuticas que los contienen, uso de dichos derivados para lapreparacion de un medicamento.
IS4224A (is) Lyfjablanda á formi dropalausnar sem inniheldur skammvirkt kalsíummótlyf af tvíhýdrópýridíngerð semvinna gegn háþrýstingi
ES2192234T3 (es) Composiciones farmaceuticas parenterales conteniendo sales de amonioalquilo de acidos 2-arilpropionicos.
KR960700061A (ko) 니코틴 의존상태 치료를 위한 약리학적 제형 (pharmaceutical composition for treating nicotine dependence)
NZ307055A (en) Immunostimulating-wound healing compositions and methods for preparing and using same
ES2052166T3 (es) Derivados de 24-homo-vitamina-d, procedimiento para su preparacion, preparados farmaceuticos que contienen estos derivados asi como su utilizacion como medicamentos.
BR0208468A (pt) Camsilato de amlodipina e processo para sua preparação
AR006401A1 (es) Compuestos de pirrolopirrolona, una composicion farmaceutica que los contiene, su uso en la fabricacion de un medicamento y en terapia, procesospara su preparación y compuestos intermediarios para dichos procesos.
BR0015939A (pt) Sistemas terapêuticos transdérmicos com estabilidade aperfeiçoada e um processo para a sua preparação
BR0112821A (pt) Formulação aperfeiçoada de aditivo para combustìvel e processo de uso
BR9304431A (pt) Medicamento processo para sua preparaçao e aplicaçao de uma mistura
ECSP941120A (es) Derivados de 1,5 benzodiazepina
DE60106406D1 (de) Zubereitungen zur anwendung als penetrationförderer in transdermalen arzneimitteln die hoch-lipophile wirkstoffe enthalten

Legal Events

Date Code Title Description
FG Grant, registration